Advertisement

Index by author

September 01, 1989; Volume 250,Issue 3

A

  1. Ahlers, S T

    1. Acute and chronic effects of corticotropin-releasing factor on schedule-controlled responding and neurochemistry of pigeons.
      J E Barrett, L Zhang, S T Ahlers and F H Wojnicki
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 788-794;
    2. Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes.
      S Gleeson, S T Ahlers, R S Mansbach, J M Foust and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 809-817;

  2. Albuquerque, E X

    1. The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects.
      M Alkondon and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 842-852;

  3. Alkondon, M

    1. The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects.
      M Alkondon and E X Albuquerque
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 842-852;

  4. Altszuler, N

    1. Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
      R W Tuman, C R Bowden, M Inman, N Altszuler and G F Tutwiler
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 836-841;

  5. Angus, P W

    1. Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.
      P W Angus, G W Mihaly, D J Morgan and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1043-1047;

  6. Arnold, W S

    1. D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
      J M Trugman, W S Arnold, N Touchet and G F Wooten
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1156-1160;

B

  1. Barrett, J E

    1. Acute and chronic effects of corticotropin-releasing factor on schedule-controlled responding and neurochemistry of pigeons.
      J E Barrett, L Zhang, S T Ahlers and F H Wojnicki
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 788-794;
    2. Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes.
      S Gleeson, S T Ahlers, R S Mansbach, J M Foust and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 809-817;

  2. Bazzato, G

    1. Effect of phthalate acid esters on transport in toad bladder membrane.
      S Sabatini, A Fracasso, G Bazzato and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 910-914;

  3. Beaune, P

    1. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
      G Labbe, V Descatoire, P Beaune, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1034-1042;

  4. Bend, J R

    1. Role of lipoxygenase, cyclooxygenase and cytochrome P-450 metabolites in contractions of isolated guinea pig pulmonary venules induced by hypoxia and anoxia.
      W R Tracey, J R Bend, J T Hamilton and N A Paterson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1097-1104;

  5. Berlan, M

    1. Obesity modifies the adrenergic status of dog adipose tissue.
      M Taosis, P Valet, L Estan, M Lafontan, P Montastruc and M Berlan
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1061-1066;

  6. Boselli, C

    1. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
      T Kenakin and C Boselli
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 944-952;

  7. Bowden, C R

    1. Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
      R W Tuman, C R Bowden, M Inman, N Altszuler and G F Tutwiler
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 836-841;

  8. Brater, D C

    1. In vitro evidence that urine composition affects the fraction of active furosemide in the nephrotic syndrome.
      J R Voelker, D M Jameson and D C Brater
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 772-778;

  9. Budai, D

    1. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
      D J Friedman, D Budai, D N Krause and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 853-859;

  10. Bueno, L

    1. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
      M Gué, J L Junien and L Bueno
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1006-1010;

C

  1. Calcagnetti, D J

    1. Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide.
      M S Fanselow, D J Calcagnetti and F J Helmstetter
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 825-830;

  2. Carini, D J

    1. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
      A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;

  3. Carr, C

    1. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.
      P R Mayeux, D E Mais, C Carr and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 923-927;

  4. Ching, M S

    1. Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
      M S Ching, D J Morgan and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1048-1054;

  5. Chiu, A T

    1. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
      A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;

  6. Churchill, P C

    1. Mechanism of cyclosporine A-induced renal vasoconstriction in the rat.
      N F Rossi, P C Churchill, F D McDonald and V R Ellis
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 896-901;

  7. Clozel, J P

    1. Effects of endothelin on regional blood flows in squirrel monkeys.
      M Clozel and J P Clozel
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1125-1131;

  8. Clozel, M

    1. Effects of endothelin on regional blood flows in squirrel monkeys.
      M Clozel and J P Clozel
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1125-1131;

  9. Cohen, M L

    1. Comparison of contractions to serotonin, carbamylcholine and prostaglandin F2 alpha in rat stomach fundus.
      R J Secrest, D D Schoepp and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 971-978;

  10. Colpaert, F C

    1. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
      W Koek, F C Colpaert, J H Woods and J M Kamenka
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1019-1027;

  11. Confort-Gouny, S

    1. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
      J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;

  12. Cory-Slechta, D A

    1. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
      D A Cory-Slechta, D V Widzowski and M C Newland
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 800-808;

  13. Coustaut, D

    1. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
      J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;

  14. Coyle, J T

    1. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line.
      M Miyamoto, T H Murphy, R L Schnaar and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1132-1140;

  15. Coyne, D W

    1. Inhibition of bradykinin-induced increases of cytosolic Ca++ by a novel amiloride analog.
      D W Coyne, M Mordhorst, E J Cragoe and A R Morrison
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 795-799;

  16. Cozzone, P J

    1. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
      J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;

  17. Cragoe, E J

    1. Inhibition of bradykinin-induced increases of cytosolic Ca++ by a novel amiloride analog.
      D W Coyne, M Mordhorst, E J Cragoe and A R Morrison
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 795-799;

D

  1. D'Ambrosio, R

    1. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
      A I Nichols, R D'Ambrosio, N A Pyszczynski and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 963-970;

  2. Daniel, E E

    1. Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.
      A G Shi, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1119-1124;

  3. Daniell, L C

    1. Ethanol and inositol 1,4,5-trisphosphate release calcium from separate stores of brain microsomes.
      L C Daniell and R A Harris
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 875-881;

  4. Descatoire, V

    1. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
      G Labbe, V Descatoire, P Beaune, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1034-1042;

  5. Desmoulin, F

    1. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
      J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;

  6. Devoisselle, J M

    1. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
      J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;

  7. Devreux, V

    1. Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets.
      P Lebrun, V Devreux, M Hermann and A Herchuelz
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1011-1018;

  8. Dolin, S J

    1. Are changes in neuronal calcium channels involved in ethanol tolerance?
      S J Dolin and H J Little
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 985-991;

  9. Duckles, S P

    1. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
      D J Friedman, D Budai, D N Krause and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 853-859;

  10. Duncia, J V

    1. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
      A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;

E

  1. Ellingboe, J

    1. Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
      J H Mendelson, N K Mello, S K Teoh and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 902-909;

  2. Ellis, V R

    1. Mechanism of cyclosporine A-induced renal vasoconstriction in the rat.
      N F Rossi, P C Churchill, F D McDonald and V R Ellis
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 896-901;

  3. Estan, L

    1. Obesity modifies the adrenergic status of dog adipose tissue.
      M Taosis, P Valet, L Estan, M Lafontan, P Montastruc and M Berlan
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1061-1066;

  4. Evans, S M

    1. Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital.
      S M Evans and C E Johanson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 779-787;

F

  1. Fanselow, M S

    1. Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide.
      M S Fanselow, D J Calcagnetti and F J Helmstetter
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 825-830;

  2. Fisher, J E

    1. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
      W Löscher, J E Fisher, H Nau and D Hönack
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1067-1078;

  3. Foust, J M

    1. Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes.
      S Gleeson, S T Ahlers, R S Mansbach, J M Foust and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 809-817;

  4. Fracasso, A

    1. Effect of phthalate acid esters on transport in toad bladder membrane.
      S Sabatini, A Fracasso, G Bazzato and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 910-914;

  5. France, C P

    1. Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys.
      C P France and W H Morse
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 928-936;
    2. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
      C P France and J H Woods
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 937-943;

  6. Friedman, D J

    1. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
      D J Friedman, D Budai, D N Krause and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 853-859;

G

  1. Gaffney, T E

    1. A stereoselective central hypotensive action of atenolol.
      A A Pearson, T E Gaffney, T Walle and P J Privitera
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 759-763;

  2. Gardner, R M

    1. Blockade of epidermal growth factor-induced uterine contractions by indomethacin or nordihydroguaritic acid.
      R M Gardner and G M Stancel
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 882-886;

  3. Gerkens, J F

    1. Cyclosporine treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstrictors and endothelium-dependent dilators.
      J F Gerkens
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1105-1112;

  4. Gleeson, S

    1. Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes.
      S Gleeson, S T Ahlers, R S Mansbach, J M Foust and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 809-817;

  5. Gordon, F J

    1. Is L-glutamate a neurotransmitter of baroreceptor information in the nucleus of the tractus solitarius?
      C Leone and F J Gordon
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 953-962;

  6. Gué, M

    1. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
      M Gué, J L Junien and L Bueno
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1006-1010;

H

  1. Halushka, P V

    1. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.
      P R Mayeux, D E Mais, C Carr and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 923-927;

  2. Hamilton, J T

    1. Role of lipoxygenase, cyclooxygenase and cytochrome P-450 metabolites in contractions of isolated guinea pig pulmonary venules induced by hypoxia and anoxia.
      W R Tracey, J R Bend, J T Hamilton and N A Paterson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1097-1104;

  3. Hanano, M

    1. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga, M Hanano and R Spector
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 979-984;

  4. Hanhijärvi, H

    1. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
      P T Männistö, H Hanhijärvi, A Havas, A Vuorela, H Komulainen and V Rauramaa
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1028-1033;

  5. Harris, R A

    1. Ethanol and inositol 1,4,5-trisphosphate release calcium from separate stores of brain microsomes.
      L C Daniell and R A Harris
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 875-881;

  6. Havas, A

    1. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
      P T Männistö, H Hanhijärvi, A Havas, A Vuorela, H Komulainen and V Rauramaa
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1028-1033;

  7. Helmstetter, F J

    1. Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide.
      M S Fanselow, D J Calcagnetti and F J Helmstetter
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 825-830;

  8. Herchuelz, A

    1. Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets.
      P Lebrun, V Devreux, M Hermann and A Herchuelz
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1011-1018;

  9. Hermann, M

    1. Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets.
      P Lebrun, V Devreux, M Hermann and A Herchuelz
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1011-1018;

  10. Hiltunen, A J

    1. Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons.
      T U Järbe, A J Hiltunen and R Mechoulam
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1000-1005;

  11. Hönack, D

    1. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
      W Löscher, J E Fisher, H Nau and D Hönack
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1067-1078;

  12. Horohonich, S

    1. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
      G A Kopia, L J Kopaciewicz, E H Ohlstein, S Horohonich, B L Storer and R J Shebuski
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 887-895;

  13. Huidobro-Toro, J P

    1. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
      S P Salas, J Roblero, H Ureta and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 992-999;

I

  1. Iga, T

    1. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga, M Hanano and R Spector
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 979-984;

  2. Inman, M

    1. Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
      R W Tuman, C R Bowden, M Inman, N Altszuler and G F Tutwiler
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 836-841;

  3. Inouye, T

    1. Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes.
      S F Steinberg, L M Kaplan, T Inouye, J F Zhang and R B Robinson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1141-1148;

J

  1. Jameson, D M

    1. In vitro evidence that urine composition affects the fraction of active furosemide in the nephrotic syndrome.
      J R Voelker, D M Jameson and D C Brater
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 772-778;

  2. Järbe, T U

    1. Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons.
      T U Järbe, A J Hiltunen and R Mechoulam
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1000-1005;

  3. Johanson, C E

    1. Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital.
      S M Evans and C E Johanson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 779-787;

  4. Johnson, A L

    1. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
      A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;

  5. Junien, J L

    1. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
      M Gué, J L Junien and L Bueno
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1006-1010;

  6. Jusko, W J

    1. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
      A I Nichols, R D'Ambrosio, N A Pyszczynski and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 963-970;

K

  1. Kamenka, J M

    1. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
      W Koek, F C Colpaert, J H Woods and J M Kamenka
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1019-1027;

  2. Kanda, A

    1. Inhibition of vagal transmission by cardiac sympathetic nerve stimulation in the dog: possible involvement of opioid receptor.
      H Koyanagawa, T Musha, A Kanda, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1092-1096;

  3. Kaplan, L M

    1. Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes.
      S F Steinberg, L M Kaplan, T Inouye, J F Zhang and R B Robinson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1141-1148;

  4. Kenakin, T

    1. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
      T Kenakin and C Boselli
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 944-952;

  5. Kimura, T

    1. Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart.
      T Musha, E Satoh, H Koyanagawa, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1087-1091;
    2. Inhibition of vagal transmission by cardiac sympathetic nerve stimulation in the dog: possible involvement of opioid receptor.
      H Koyanagawa, T Musha, A Kanda, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1092-1096;

  6. Kitamura, K

    1. Inhibitory actions of a novel benzothiazepine derivative, TA3090, on the electrical and mechanical responses of the rabbit mesenteric artery.
      E Nishiye, K Nakao, K Kitamura and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1079-1086;

  7. Koek, W

    1. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
      W Koek, F C Colpaert, J H Woods and J M Kamenka
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1019-1027;

  8. Komulainen, H

    1. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
      P T Männistö, H Hanhijärvi, A Havas, A Vuorela, H Komulainen and V Rauramaa
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1028-1033;

  9. Kopaciewicz, L J

    1. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
      G A Kopia, L J Kopaciewicz, E H Ohlstein, S Horohonich, B L Storer and R J Shebuski
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 887-895;

  10. Kopia, G A

    1. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
      G A Kopia, L J Kopaciewicz, E H Ohlstein, S Horohonich, B L Storer and R J Shebuski
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 887-895;

  11. Koyanagawa, H

    1. Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart.
      T Musha, E Satoh, H Koyanagawa, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1087-1091;
    2. Inhibition of vagal transmission by cardiac sympathetic nerve stimulation in the dog: possible involvement of opioid receptor.
      H Koyanagawa, T Musha, A Kanda, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1092-1096;

  12. Krause, D N

    1. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
      D J Friedman, D Budai, D N Krause and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 853-859;

  13. Kuriyama, H

    1. Inhibitory actions of a novel benzothiazepine derivative, TA3090, on the electrical and mechanical responses of the rabbit mesenteric artery.
      E Nishiye, K Nakao, K Kitamura and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1079-1086;

  14. Kurtzman, N A

    1. Effect of phthalate acid esters on transport in toad bladder membrane.
      S Sabatini, A Fracasso, G Bazzato and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 910-914;

  15. Kwan, C Y

    1. Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.
      A G Shi, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1119-1124;

L

  1. Labbe, G

    1. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
      G Labbe, V Descatoire, P Beaune, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1034-1042;

  2. Lafontan, M

    1. Obesity modifies the adrenergic status of dog adipose tissue.
      M Taosis, P Valet, L Estan, M Lafontan, P Montastruc and M Berlan
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1061-1066;

  3. Laird, H E

    1. Solubilization and characterization of the liver peripheral-type benzodiazepine receptor.
      A L Parola, C W Putnam, D H Russell and H E Laird
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1149-1155;

  4. Larrey, D

    1. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
      G Labbe, V Descatoire, P Beaune, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1034-1042;

  5. Leatherman, D L

    1. Differential association of T-2 and T-2 tetraol with mammalian cells.
      J L Middlebrook and D L Leatherman
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 860-866;

  6. Lebrun, P

    1. Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets.
      P Lebrun, V Devreux, M Hermann and A Herchuelz
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1011-1018;

  7. Leone, C

    1. Is L-glutamate a neurotransmitter of baroreceptor information in the nucleus of the tractus solitarius?
      C Leone and F J Gordon
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 953-962;

  8. Letteron, P

    1. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
      G Labbe, V Descatoire, P Beaune, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1034-1042;

  9. Little, H J

    1. Are changes in neuronal calcium channels involved in ethanol tolerance?
      S J Dolin and H J Little
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 985-991;

  10. Löscher, W

    1. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
      W Löscher, J E Fisher, H Nau and D Hönack
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1067-1078;

M

  1. Mais, D E

    1. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.
      P R Mayeux, D E Mais, C Carr and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 923-927;

  2. Malik, K U

    1. Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat.
      D D Schwartz and K U Malik
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 764-771;

  3. Männistö, P T

    1. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
      P T Männistö, H Hanhijärvi, A Havas, A Vuorela, H Komulainen and V Rauramaa
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1028-1033;

  4. Mansbach, R S

    1. Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes.
      S Gleeson, S T Ahlers, R S Mansbach, J M Foust and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 809-817;

  5. Masson, S

    1. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
      J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;

  6. Mayeux, P R

    1. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.
      P R Mayeux, D E Mais, C Carr and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 923-927;

  7. McCall, D E

    1. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
      A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;

  8. McDonald, F D

    1. Mechanism of cyclosporine A-induced renal vasoconstriction in the rat.
      N F Rossi, P C Churchill, F D McDonald and V R Ellis
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 896-901;

  9. Mechoulam, R

    1. Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons.
      T U Järbe, A J Hiltunen and R Mechoulam
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1000-1005;

  10. Mello, N K

    1. Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
      J H Mendelson, N K Mello, S K Teoh and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 902-909;

  11. Mendelson, J H

    1. Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
      J H Mendelson, N K Mello, S K Teoh and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 902-909;

  12. Middlebrook, J L

    1. Differential association of T-2 and T-2 tetraol with mammalian cells.
      J L Middlebrook and D L Leatherman
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 860-866;

  13. Mihaly, G W

    1. Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.
      P W Angus, G W Mihaly, D J Morgan and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1043-1047;

  14. Minami, Y

    1. Possible involvement of 5-lipoxygenase products in the generation of endothelium-derived relaxing factor.
      Y Minami and N Toda
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1055-1060;

  15. Miyamoto, M

    1. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line.
      M Miyamoto, T H Murphy, R L Schnaar and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1132-1140;

  16. Montastruc, P

    1. Obesity modifies the adrenergic status of dog adipose tissue.
      M Taosis, P Valet, L Estan, M Lafontan, P Montastruc and M Berlan
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1061-1066;

  17. Mordhorst, M

    1. Inhibition of bradykinin-induced increases of cytosolic Ca++ by a novel amiloride analog.
      D W Coyne, M Mordhorst, E J Cragoe and A R Morrison
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 795-799;

  18. Morgan, D J

    1. Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.
      P W Angus, G W Mihaly, D J Morgan and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1043-1047;
    2. Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
      M S Ching, D J Morgan and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1048-1054;

  19. Morrison, A R

    1. Inhibition of bradykinin-induced increases of cytosolic Ca++ by a novel amiloride analog.
      D W Coyne, M Mordhorst, E J Cragoe and A R Morrison
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 795-799;

  20. Morrison, W J

    1. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
      W J Morrison and S D Shukla
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 831-835;

  21. Morse, W H

    1. Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys.
      C P France and W H Morse
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 928-936;

  22. Murphy, T H

    1. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line.
      M Miyamoto, T H Murphy, R L Schnaar and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1132-1140;

  23. Musha, T

    1. Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart.
      T Musha, E Satoh, H Koyanagawa, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1087-1091;
    2. Inhibition of vagal transmission by cardiac sympathetic nerve stimulation in the dog: possible involvement of opioid receptor.
      H Koyanagawa, T Musha, A Kanda, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1092-1096;

N

  1. Nakao, K

    1. Inhibitory actions of a novel benzothiazepine derivative, TA3090, on the electrical and mechanical responses of the rabbit mesenteric artery.
      E Nishiye, K Nakao, K Kitamura and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1079-1086;

  2. Nau, H

    1. Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
      W Löscher, J E Fisher, H Nau and D Hönack
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1067-1078;

  3. Newland, M C

    1. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
      D A Cory-Slechta, D V Widzowski and M C Newland
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 800-808;

  4. Nichols, A I

    1. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
      A I Nichols, R D'Ambrosio, N A Pyszczynski and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 963-970;

  5. Nishiye, E

    1. Inhibitory actions of a novel benzothiazepine derivative, TA3090, on the electrical and mechanical responses of the rabbit mesenteric artery.
      E Nishiye, K Nakao, K Kitamura and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1079-1086;

O

  1. Ohlstein, E H

    1. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
      G A Kopia, L J Kopaciewicz, E H Ohlstein, S Horohonich, B L Storer and R J Shebuski
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 887-895;

P

  1. Parola, A L

    1. Solubilization and characterization of the liver peripheral-type benzodiazepine receptor.
      A L Parola, C W Putnam, D H Russell and H E Laird
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1149-1155;

  2. Paterson, N A

    1. Role of lipoxygenase, cyclooxygenase and cytochrome P-450 metabolites in contractions of isolated guinea pig pulmonary venules induced by hypoxia and anoxia.
      W R Tracey, J R Bend, J T Hamilton and N A Paterson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1097-1104;

  3. Pearson, A A

    1. A stereoselective central hypotensive action of atenolol.
      A A Pearson, T E Gaffney, T Walle and P J Privitera
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 759-763;

  4. Pessayre, D

    1. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
      G Labbe, V Descatoire, P Beaune, P Letteron, D Larrey and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1034-1042;

  5. Price, W A

    1. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
      A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;

  6. Privitera, P J

    1. A stereoselective central hypotensive action of atenolol.
      A A Pearson, T E Gaffney, T Walle and P J Privitera
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 759-763;

  7. Putnam, C W

    1. Solubilization and characterization of the liver peripheral-type benzodiazepine receptor.
      A L Parola, C W Putnam, D H Russell and H E Laird
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1149-1155;

  8. Pyszczynski, N A

    1. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
      A I Nichols, R D'Ambrosio, N A Pyszczynski and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 963-970;

R

  1. Rauramaa, V

    1. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
      P T Männistö, H Hanhijärvi, A Havas, A Vuorela, H Komulainen and V Rauramaa
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1028-1033;

  2. Robinson, R B

    1. Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes.
      S F Steinberg, L M Kaplan, T Inouye, J F Zhang and R B Robinson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1141-1148;

  3. Roblero, J

    1. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
      S P Salas, J Roblero, H Ureta and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 992-999;

  4. Rossi, N F

    1. Mechanism of cyclosporine A-induced renal vasoconstriction in the rat.
      N F Rossi, P C Churchill, F D McDonald and V R Ellis
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 896-901;

  5. Russell, D H

    1. Solubilization and characterization of the liver peripheral-type benzodiazepine receptor.
      A L Parola, C W Putnam, D H Russell and H E Laird
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1149-1155;

S

  1. Sabatini, S

    1. Effect of phthalate acid esters on transport in toad bladder membrane.
      S Sabatini, A Fracasso, G Bazzato and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 910-914;

  2. Salas, S P

    1. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
      S P Salas, J Roblero, H Ureta and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 992-999;

  3. Satoh, E

    1. Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart.
      T Musha, E Satoh, H Koyanagawa, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1087-1091;

  4. Satoh, S

    1. Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart.
      T Musha, E Satoh, H Koyanagawa, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1087-1091;
    2. Inhibition of vagal transmission by cardiac sympathetic nerve stimulation in the dog: possible involvement of opioid receptor.
      H Koyanagawa, T Musha, A Kanda, T Kimura and S Satoh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1092-1096;

  5. Sawada, Y

    1. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga, M Hanano and R Spector
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 979-984;

  6. Schnaar, R L

    1. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line.
      M Miyamoto, T H Murphy, R L Schnaar and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1132-1140;

  7. Schoepp, D D

    1. Comparison of contractions to serotonin, carbamylcholine and prostaglandin F2 alpha in rat stomach fundus.
      R J Secrest, D D Schoepp and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 971-978;

  8. Schwartz, D D

    1. Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat.
      D D Schwartz and K U Malik
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 764-771;

  9. Sciaky, M

    1. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
      J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;

  10. Secrest, R J

    1. Comparison of contractions to serotonin, carbamylcholine and prostaglandin F2 alpha in rat stomach fundus.
      R J Secrest, D D Schoepp and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 971-978;

  11. Shebuski, R J

    1. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
      G A Kopia, L J Kopaciewicz, E H Ohlstein, S Horohonich, B L Storer and R J Shebuski
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 887-895;

  12. Shi, A G

    1. Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.
      A G Shi, C Y Kwan and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1119-1124;

  13. Shukla, S D

    1. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
      W J Morrison and S D Shukla
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 831-835;

  14. Sivam, S P

    1. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
      S P Sivam
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 818-824;

  15. Smallwood, R A

    1. Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.
      P W Angus, G W Mihaly, D J Morgan and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1043-1047;
    2. Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
      M S Ching, D J Morgan and R A Smallwood
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1048-1054;

  16. Sosnowski, M

    1. Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord.
      M Sosnowski, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 915-922;

  17. Spector, R

    1. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga, M Hanano and R Spector
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 979-984;

  18. Stancel, G M

    1. Blockade of epidermal growth factor-induced uterine contractions by indomethacin or nordihydroguaritic acid.
      R M Gardner and G M Stancel
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 882-886;

  19. Steinberg, S F

    1. Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes.
      S F Steinberg, L M Kaplan, T Inouye, J F Zhang and R B Robinson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1141-1148;

  20. Stevens, C W

    1. Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord.
      M Sosnowski, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 915-922;

  21. Storer, B L

    1. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
      G A Kopia, L J Kopaciewicz, E H Ohlstein, S Horohonich, B L Storer and R J Shebuski
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 887-895;

  22. Sugiyama, Y

    1. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga, M Hanano and R Spector
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 979-984;

  23. Suzuki, H

    1. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga, M Hanano and R Spector
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 979-984;

T

  1. Taosis, M

    1. Obesity modifies the adrenergic status of dog adipose tissue.
      M Taosis, P Valet, L Estan, M Lafontan, P Montastruc and M Berlan
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1061-1066;

  2. Teoh, S K

    1. Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
      J H Mendelson, N K Mello, S K Teoh and J Ellingboe
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 902-909;

  3. Thoolen, M J

    1. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
      A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;

  4. Timmermans, P B

    1. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
      A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;

  5. Toda, N

    1. Possible involvement of 5-lipoxygenase products in the generation of endothelium-derived relaxing factor.
      Y Minami and N Toda
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1055-1060;

  6. Touchet, N

    1. D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
      J M Trugman, W S Arnold, N Touchet and G F Wooten
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1156-1160;

  7. Tracey, W R

    1. Role of lipoxygenase, cyclooxygenase and cytochrome P-450 metabolites in contractions of isolated guinea pig pulmonary venules induced by hypoxia and anoxia.
      W R Tracey, J R Bend, J T Hamilton and N A Paterson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1097-1104;

  8. Trugman, J M

    1. D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
      J M Trugman, W S Arnold, N Touchet and G F Wooten
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1156-1160;

  9. Tuman, R W

    1. Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
      R W Tuman, C R Bowden, M Inman, N Altszuler and G F Tutwiler
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 836-841;

  10. Tutwiler, G F

    1. Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
      R W Tuman, C R Bowden, M Inman, N Altszuler and G F Tutwiler
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 836-841;

U

  1. Ureta, H

    1. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
      S P Salas, J Roblero, H Ureta and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 992-999;

V

  1. Valet, P

    1. Obesity modifies the adrenergic status of dog adipose tissue.
      M Taosis, P Valet, L Estan, M Lafontan, P Montastruc and M Berlan
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1061-1066;

  2. Vion-Dury, J

    1. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
      J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;

  3. Voelker, J R

    1. In vitro evidence that urine composition affects the fraction of active furosemide in the nephrotic syndrome.
      J R Voelker, D M Jameson and D C Brater
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 772-778;

  4. Vuorela, A

    1. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
      P T Männistö, H Hanhijärvi, A Havas, A Vuorela, H Komulainen and V Rauramaa
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1028-1033;

W

  1. Walle, T

    1. A stereoselective central hypotensive action of atenolol.
      A A Pearson, T E Gaffney, T Walle and P J Privitera
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 759-763;

  2. Widzowski, D V

    1. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
      D A Cory-Slechta, D V Widzowski and M C Newland
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 800-808;

  3. Wojnicki, F H

    1. Acute and chronic effects of corticotropin-releasing factor on schedule-controlled responding and neurochemistry of pigeons.
      J E Barrett, L Zhang, S T Ahlers and F H Wojnicki
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 788-794;

  4. Wong, P C

    1. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
      A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;

  5. Woods, J H

    1. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
      W Koek, F C Colpaert, J H Woods and J M Kamenka
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1019-1027;
    2. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
      C P France and J H Woods
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 937-943;

  6. Wooten, G F

    1. D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
      J M Trugman, W S Arnold, N Touchet and G F Wooten
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1156-1160;

Y

  1. Yaksh, T L

    1. Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord.
      M Sosnowski, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 915-922;

Z

  1. Zhang, J F

    1. Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes.
      S F Steinberg, L M Kaplan, T Inouye, J F Zhang and R B Robinson
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1141-1148;

  2. Zhang, L

    1. Acute and chronic effects of corticotropin-releasing factor on schedule-controlled responding and neurochemistry of pigeons.
      J E Barrett, L Zhang, S T Ahlers and F H Wojnicki
      Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 788-794;
Back to top

In this issue

Advertisement